Floatz logo

Raloxifene

Menopausal Symptoms

OHSU Knight Cancer InstituteSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Menopausal Symptoms cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Anglo Celtic Cooperative Oncology Group
Phase 3BB
Zoladex
Anglo Celtic Cooperative Oncology Group
Phase 3BB
ESTROGENS, CONJUGATED
Institute of Cancer Research, United Kingdom
Phase 3BB
17-beta-estradiol
Regional Oncologic Center
Phase 3BB
LENVATINIB
Anglo Celtic Cooperative Oncology Group
Phase 3BB

View all 10 →

Same molecule, other indications

Raloxifene is also rated in:

schizophreniform disorderDormant
A
Indicative ·
83 / 100
View asset →
schizoaffective disorderDormant
BBB
Indicative ·
77 / 100
View asset →
schizophreniaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →